Long-term acceptance of major histocompatibility complex-mismatched cardiac allograft induced by a low dose of CTLA4IgM plus FK506
- PMID: 8865157
- DOI: 10.1111/j.1348-0421.1996.tb01102.x
Long-term acceptance of major histocompatibility complex-mismatched cardiac allograft induced by a low dose of CTLA4IgM plus FK506
Abstract
The immunosuppressant FK506 prolongs allograft survival. However, at therapeutic doses it has significant side effects. A fusion protein consisting of the extracellular portion of CTLA4 and the Fc portion of human IgG (CTLA4IgG) also prolongs allograft survival, but large doses of CTLA4IgG are required for the induction of cardiac allograft acceptance. Therefore, we constructed a pentameric form of a new CTLA4 fusion protein, CTLA4IgM. We tested whether low doses of CTLA4IgG or CTLA4IgM in combination with subtherapeutic doses of FK506 can prolong allograft survival in a synergistic fashion. C57BL/6 (H-2b) neonatal hearts were transplanted to CBA/J (H-2b) mice in a heterotopic, nonvascularized cardiac allograft model. The findings demonstrate that a combination of low doses of FK506 plus a pentameric form of CTLA4Ig, CTLA4IgM, leads to significant graft survival, while a combination of FK506 plus CTLA4IgG does not.
Similar articles
-
Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance.Transplantation. 1994 Mar 15;57(5):736-40. doi: 10.1097/00007890-199403150-00017. Transplantation. 1994. PMID: 7511258
-
Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.Transplantation. 1996 Oct 15;62(7):1011-8. doi: 10.1097/00007890-199610150-00021. Transplantation. 1996. PMID: 8878397
-
The effect of combination cyclosporine and CTLA4-Ig therapy on cardiac allograft survival.J Surg Res. 1994 Jul;57(1):60-4. doi: 10.1006/jsre.1994.1110. J Surg Res. 1994. PMID: 8041150
-
Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion.J Exp Med. 1993 Nov 1;178(5):1801-6. doi: 10.1084/jem.178.5.1801. J Exp Med. 1993. PMID: 8228826 Free PMC article.
-
Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.Transplantation. 1997 Dec 27;64(12):1646-50. doi: 10.1097/00007890-199712270-00003. Transplantation. 1997. PMID: 9422396
Cited by
-
Disturbed CD4+ T cell homeostasis and in vitro HIV-1 susceptibility in transgenic mice expressing T cell line-tropic HIV-1 receptors.J Exp Med. 1998 May 4;187(9):1439-49. doi: 10.1084/jem.187.9.1439. J Exp Med. 1998. PMID: 9565636 Free PMC article.
-
[Regulation of T-cell activation by CD28 and CTLA-4].Med Klin (Munich). 1998 Oct 15;93(10):592-7. doi: 10.1007/BF03042674. Med Klin (Munich). 1998. PMID: 9849050 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
